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Abstract
Hepatitis E virus (HEV) is a common cause of waterborne epidemics of acute hepatitis worldwide, but its natural history, ecology, clinical
significance and presentation are entirely different in the developed world, where, apart from the typical travel-associated imported cases,
the majority of the observed cases involve older adults with comorbidities or forms of immune compromise who acquire HEV genotype 3,
mostly through direct or indirect (consumption of meat products) contact with pigs. Thus, HEV is zoonotic in the developed world, a fact
that has been recently recognized, and is of major importance in medical, veterinary and public health terms. The present article evaluates
the current knowledge about the zoonotic nature of HEV in the industrialized world, outlines the numerous questions that still exist
regarding the role of pigs in viral ecology, summarizes knowledge about clinical disease in its zoonotic form, and discusses where future
scientific efforts should focus.
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Introduction
Hepatitis E virus (HEV) is, together with hepatitis A virus
(HAV), the commonest cause of waterborne epidemics of
acute hepatitis worldwide; it has been recognized recently,
but has been implicated in historical epidemics, particularly in
the Indian Peninsula. Its natural history is strikingly different
in the developed world, where waterborne hepatitis out-
breaks are very rare events; however, the virus causes human
disease to a small but significant extent, probably as a
zoonotic agent transmitted through contact with pigs and
consumption of pork products, and endangering specific
populations with different forms of immunodeficiency. The
zoonotic nature of HEV has only recently been recognized,
and is currently the subject of intense speculation by
veterinary, food and medical authorities, with novel data
being continuously added: the present review aims to
summarize the current knowledge on the zoonotic, pig-
related parameters of HEV.
History
The first outbreak officially attributed to HEV was recorded in
India, in 1978–1979, when 275 patients developed acute
hepatitis in neighbouring villages with a common water source
(out of a population of almost 16 000): 120 fulminant cases
were reported, and ten of them died—attack rates were
higher in younger persons, and both severity and mortality
were markedly higher in pregnant women. A similar pattern
was retrospectively recognized in a New Delhi 1955–1956
outbreak of acute hepatitis related to contaminated water
supplies resulting from flooding, with 29 000 icteric cases
being reported, the majority of them benign, apart from
pregnant women [1].
In 1983, Mikhail Balayan self-inoculated himself with con-
taminated faecal extract from patients of a non-HAV/non-
hepatitis B virus outbreak of acute hepatitis; he developed
acute hepatitis 5 weeks later, and shedded virus-like-particles
in his faeces [2].
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In the early 1990s, Reyes was the first to recognize part of
the viral genome in a biliary extract from an animal model [3],
and, subsequently, genome sequencing was rapidly achieved, as
well as the characterization of two heterogeneous isolates, the
Asian and Mexican isolates. The virus was named hepatitis E
virus because E was the next available letter in the hepatitis
virus group, but also to denote the endemic and epidemic
potential of the pathogen [4]. In the following years, swine
HEV and its zoonotic potential were characterized, and
interest resurfaced when more cases of chronic infection of
immunosuppressed individuals started to surface, particularly
in transplanted patients.
At present, two subunit vaccines are available, although they
are, as yet, of indeterminate utility (they were successful in
phase II–III trials, but queries exist regarding their use in
children, in pregnant women, and as post-exposure prophy-
laxis, and regarding their efficacy against genotype 3) [5]. The
current estimates of disease burden reach 3 000 000 annual
cases, which are possibly responsible for approximately 70 000
deaths [6].
The Virus
HEV is a small (27–34 nm in diameter) spherical virus with
characteristic protrusions, and is the only member of the
family Hepeviridae. Four genotypes are recognized, with
numerous subgenotypes. The genotypes have different geo-
graphical distributions, with genotype 1 (subgenotypes 1a–1e)
in Asia and Africa, genotype 2 (subgenotypes 2a and 2b) in
western Africa and Mexico, genotype 3 (subgenotypes 3a–3j)
in the Western world, and genotype 4 (subgenotypes 4a–4g)
in eastern Asia [7]. The first two genotypes cause more severe
human disease than the latter two, although genotype 3 is the
one implicated in chronic infection of immunosuppressed
patients. An isolate previously considered to belong to
genotype 5 (avian HEV) shows little homology with the
mammalian genotypes, and should be considered to be of a
different nature.
The animal reservoir of HEV is abundant: it has been
recognized in almost all domestic animals, as well as in rodents
and wildlife species (such as deer, boars, and rabbits). HEV is
isolated from pigs all over the world, irrespective of the
incidence of human disease: pigs are infected early in life,
seroconvert, but do not develop disease. Genotypes 3 and 4
are predominant in pigs, again irrespective of the genotype that
is predominant in human cases in a particular area [8].
The virus is inactivated by cooking, with the concentration
decreasing by 0.48 log after 1 min at 70°C, and by more than
3 log when a cooking temperature of >95°C is reached.
Human Disease: the Endemic and the
Zoonotic
HEV is predominantly a waterborne and foodborne pathogen,
although transmission through transfusion and vertical trans-
mission have been reported, and direct person-to-person
transmission has also been reported, although extremely
rarely (even in outbreaks, and in contrast to HAV, which has a
high attack rate in the families of the afflicted). The incubation
period ranges from 2 to 8 weeks, with an average of 5–
6 weeks, and the development or not of symptoms has been
shown to be infectious dose-dependent in animal models.
The clinical presentation varies according to endemic/
epidemic patterns: In endemic areas, massive prolonged
outbreaks of waterborne hepatitis are typical, with attack
rates ranging from 1% to 25%, and the disease mainly affecting
young adults, with children remaining asymptomatic. Infection
is fulminant in pregnant women, for pathophysiological reasons
that remain obscure (possibly related to reduced expression of
a progesterone receptor), and all aspects of pregnancy
(stillbirth, premature birth, and spontaneous abortions) are
affected [9]. Asymptomatic persons in endemic areas have
been considered to be potential disease reservoirs who shed
the virus, enabling its ecological persistence. Symptoms vary
from asymptomatic mild elevation of hepatic biochemistry
indices to fulminant disease and death. Decompensation of
pre-existing chronic liver disease is also an issue in such
outbreaks. Therapy is usually supportive.
In the developed world, the clinical presentation is different:
although most cases were initially typical cases of acute
hepatitis occurrring soon after international travel to an
endemic area, the number of autochthonous cases is increas-
ing, and these cases have been recognized as zoonotic in at
least five circumstances worldwide—in a minor outbreak in
Japan related to wild deer, and through the consumption of
pork sausage products in Japan, the USA, France, and The
Netherlands [10,11]—but also in sporadic cases related to
undercooked or raw pork product consumption. In these
cases, the zoonotic nature of the infection was either directly
demonstrated (when there was homology between patient
HEV RNA and HEV RNA isolated from the remainder of the
implicated meat product) or concluded indirectly (the devel-
opment of acute hepatitis with strong antibody response
against HEV in the immediate—up to 2 months—period after
the consumption of potentially undercooked or raw pork
products). A recent pooled analysis by Lewis et al. [12] of all of
the autochthonous HEV cases adequately diagnosed in Europe,
the total of which approached 150 cases from eight countries,
found that almost all of the cases were caused by genotype 3,
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases, CMI, 19, 600–604
CMI Christou and Kosmidou Hepatitis E virus in the Western world 601
and that the majority of them involved older adults, the
majority of whom had comorbidities. In a recent French report
[11], disease developed in seven of 13 members of three
families who jointly consumed figatelli (raw sausages made
from pig livers, a Corsican special dish), whereas none of the
remaining five members, who did not consume figatelli,
developed disease. In the same study, HEV RNA was detected
in the majority of commercially sold figatelli sausages. Recent
French studies underline that the significance of genotype 4 in
the zoonotic autochthonous HEV cases may be underesti-
mated [13]. In a recent study from Japan, HEV RNA
(genotype 4), implicated in three cases of acute hepatitis in
Japan (two of them fulminant), was identical in all cases, and the
route of infection was traced to a specific barbecue restaurant,
where all three patients had consumed grilled pig meat and
entrails [14].
The novel pattern of disease in the developed world is
observed in immunosuppressed transplanted individuals,
where genotype 3 HEV can show chronicity and also induce
neurological (in 2–5%) and even renal complications. Low
platelet numbers and the use of tacrolimus have been
considered as potential risk factors [15].
HEV as a Zoonotic Agent
It should be noted that seroprevalence studies are extremely
unreliable for evaluating the burden of HEV: the seropreva-
lence, for example, is only 20% in India, where the greatest
number and the most important outbreaks occur, whereas it is
>70% in Egypt, where outbreaks have not been reported. The
NHANES studies have also shown relatively high seropreva-
lence rates in the USA, and a similar pattern has been observed
in the rest of the developed world, with prevalence rates
reaching 20% in some studies, particularly in specific popula-
tions working in pig/pork-related occupations and in veteri-
narians. This seroprevalence anomaly can be explained by the
variation in genotype prevalence: animal strains in the devel-
oped world can be considered to be attenuated, inducing an
immune response but no, or minor and non-recorded, clinical
disease, apart from in certain immunocompromised individuals.
Genotype 3 (and, to a lesser extent, genotype 4) strains
isolated from human HEV cases have shown sequence
homology with strains isolated from pigs, thus indicating the
zoonotic nature of the disease. Furthermore, the ability of the
virus to cross the species barrier was demonstrated in the
early 1990s, by Balayan [16], who demonstrated that human
strains can infect pigs (in a reverse zoonotic process). The
seropositivity of pigs is extremely high in the developed world,
reaching 80% in the British pig population [17]. Positivity may
vary according to the method used for each study: if herds are
studied instead of individual animals, one has to determine how
many positive animals are needed for the whole herd to be
considered as positive; furthermore, positivity may differ
according to the detection method used (antibodies vs.
RNA) and the sample source (blood, faecal samples, and
commercial preparations). In general, however, it is accepted
that most pigs seroconvert early, and, by the age of 4 months,
most studied animals have been found to be positive in
numerous studies worldwide. Faecal shedding of HEV by pigs
corresponds with the early stage of contact with the virus,
most studies showing that it is significant between week 12
and week 18 of life [8]. An increasingly understood reservoir
may be the wild boar population, with seroprevalence rates
ranging from 17% to 42% in studies from numerous European
countries and also Australia and Japan.
The evaluation of autochthonous cases in the developed
world has shown that populations at risk include veterinarians
(a 2002 US study showed that 23% of veterinarians were
genotype 3-positive vs. 17% of healthy blood donors [18], and,
through a Bayesian approach, seropositivity in The Nether-
lands was determined to be 11% for pig veterinarians, 6% for
non-pig veterinarians, and 2% for the general population [19]),
persons occupied in farms in contact with pigs (a 2001
Moldova study showed 51% seropositivity in such workers, as
compared with 25% in healthy controls [20]), and also wildlife
travellers exposed to rodents, and persons consuming inad-
equately cooked pork liver, and inadequately cooked or raw
pig, deer or boar meat—in the latter cases, clusters of cases
are typically observed, as already described above. A report
incriminated a pet pig in the transmission of HEV, underlining
the potential for a role of direct contact in zoonotic
transmission [21].
HEV RNA has been detected in 2% of pig liver products
commercially sold in Japan, and in 11% of analogous products
sold in the USA: this detection refers essentially to infectious
virus, which can cause human disease if it is not inactivated by
boiling or stir-frying for at least 5 min. A recent large German
study detected HEV RNA in 4% of commercially sold pig liver
products, with significant sequence homology to strains
implicated in human HEV cases in the area [22].
On the basis of only the above, could one consider pigs to
constitute the definite reservoir for human disease in the
developed world? One could object that there may be another
reservoir that is common for animals and humans, e.g. water
or waste water. Another obscure issue is the prevalence of
genotype 1 in India in human cases, despite the high prevalence
of genotype 3 in pigs (although one can assume that there is
ecological competition between the two genotypes in such
areas, which is responsible for the increased circulation of
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genotype 1 in human disease; or one can assume that, in the
vast number of cases attributed to genotype 1 outbreaks, the
few genotype 3 zoonotic cases remain unrecognized).
However, further surveillance data demonstrate that pigs
constitute the reservoir, and are able to shed the virus into the
environment [23]: Sewage water from a pig slaughterhouse in
Spain was shown to contain HEV that was similar to the
indigenous Spanish human strain, and HEV has been repeatedly
detected in pig manure storage facilities (concrete pits and
lagoons). In a study in an Iowa farm, in particular [24], 15 of 22
concrete pits and three of eight lagoons that served as storage
facilities were positive for RNA of genotype 3 HEV, which
could subsequently contaminate water and even spread across
the species barrier: for example, in South Korea, oysters have
been shown to be positive for genotype 3 HEV that is
homologous to the Korean pig genotype 3 [25]. Another
dimension to the environmental spread of HEV was shown by
a Dutch study [26], which demonstrated that 17% of surface
water samples evaluated were HEV-positive.
We thus have a pattern for the industrialized world ecology
of HEV: the HEV that is abundant in the pig population can be
shed into the environment, and, directly or indirectly, be
transmitted to humans, usually causing only a seroconverting
immune response, and rarely major, acute or chronic disease,
in special at-risk patients. However, because the numbers of
these at-risk patients are rapidly increasing, owing to increased
life-expectancy (and a consequent increase in the elderly
population with more comorbidities), and the extended
survival of patients who undergo transplantation, a public
health issue is arising: exactly how high is the risk in such
patients? How thoroughly should they be educated regarding
their dietary habits and their contact with potential animal or
environmental reservoirs? Is there a role for the available
subunit vaccines in such patients (both in terms of risk/benefit
ratio and in terms of the understudied immunogenic proper-
ties of the vaccines in immunocompromised individuals)? How
thoroughly should regional and international public health
officials investigate the presence of the virus in pig populations,
and how strict (and how effective) should waste disposal rules
regarding farms, pigsties and slaughterhouses be?
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